莫沙必利与多潘立酮治疗功能性消化不良的临床效果比较
黄小炎
（泰兴市第三人民医院，江苏 泰兴，225400）
浏览次数：226次 下载次数：371次
摘要：
目的 比较莫沙必利与多潘立酮治疗功能性消化不良的临床效果。方法 选取2013年1月1日至2015年12月31日于我院就诊的功能性消化不良的患者共74例，将患者随机分为A 组和B组，各37例，A组患者采用莫沙必利治疗，B组患者采用多潘立酮治疗，比较两组患者的治疗效果及用药安全性。结果 A组患者治疗总有效率明显高于B组患者，且复发率明 显低于B组（P<0.05）；A组患者不良反应总发生率明显低于B组患者（P<0.05）。结论 莫沙必利治疗功能性消化不良效果比多潘立酮更为显著且疗效持久，用药不良反应少，是一种安全有效的治疗方式，值得临床应用。
关键词：莫沙必利；多潘立酮；功能性消化不良
中图分类号：R574.4文献标志码：A文章编号：2096-1413(2017)31-0032-02
Clinical curative effect comparison of mosapride and domperidone in the treatment of functional dyspepsia
HUANG Xiao-yan
(the Third People忆s Hospital of Taixing, Taixing 225400, China)
ABSTRACT: Objective To compare the clinical effects of mosapride and domperidone in the treatment of functional dyspepsia. Methods From January 1, 2013 to December 31, 2015, a total of 74 cases of patients with functional dyspepsia in our hospital were selected and randomly divided into A group and B group, with 37 cases in each group. A group was given mosapride and B group was treated with domperidone. The therapeutic effects and safety of the two groups were compared. Results The total therapeutic effect of A group was significantly higher than that of B group, and recurrence rate was significantly lower than that of B group (P<0.05). The total incidence rate of adverse reaction of A group was significantly lower than that of B group (P<0.05). Conclusion Compared with domperidone, the treatment of mosapride for patients with functional dyspepsia has more remarkable effect with lasting efficacy and less adverse reactions, which is a safe treatment method and worthy of application.
KEYWORDS: mosapride; domperidone; functional dyspepsia
参考文献：
[1] 邱燕.莫沙必利与多潘立酮治疗功能性消化不良疗效分析[J].北方药学,2015,12(2):120.
[2] 王果,王皓,李红艳.曲美布汀治疗功能性消化不良疗效及安全性 的研究[J].医师进修杂志,2004,27(5):22-24.
[3] 张兴华.莫沙必利、多潘立酮在消化不良(功能性)治疗过程中的作 用分析[J].现代养生(月刊),2016,9(9):74.
[4] 仇俊鹏.莫沙比利和多潘立酮治疗功能性消化不良的临床分析[J]. 吉林医学,2011,32(21):4359-4360.
[5] 刘若吟,黄绍鹏,邵卫华.莫沙必利治疗功能性消化不良及近端胃 舒张和胃排空功能的临床疗效[J].北方药学,2016,13(2):28-29.
[6] 赵永亮.莫沙必利治疗功能性消化不良的效果与安全性分析[J].河 南医学研究,2016,25(10):1870-1871.
[7] 肖兵,侯乐,麦泳仪.莫沙必利治疗功能性消化不良的疗效和安全 性分析[J].海峡药学,2016,28(5):175-176.
[8] 陈坚强.多潘立酮和莫沙必利治疗功能性消化不良的疗效观察[J]. 中国药物经济学,2014,9(S2):161-162.
[9] 李荣焕.莫沙必利治疗功能性消化不良的临床疗效和安全性分析 [J].中国处方药,2015,13(9):73-74.
[10] 黄莹太.对比分析用莫沙必利与多潘立酮治疗功能性消化不良 的临床疗效[J].当代医药论丛,2014,12(15):256-257.